Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 145

    1.

    The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C.

    Gutierrez AD, de Serna DG, Robinson I, Schade DS.

    Metabolism. 2009 Apr;58(4):469-78.PMID: 19303966 [PubMed - indexed for MEDLINE]Related articles

    2.

    Impaired orthostatic response in patients with type 2 diabetes mellitus after 48 hours of bed rest.

    Schneider SM, Robergs RA, Amorim FT, de Serna DG, Duran-Valdez EE, Schade DS.

    Endocr Pract. 2009 Mar;15(2):104-10.PMID: 19289319 [PubMed - indexed for MEDLINE]Related articles

    3.

    Use of a continuous glucose monitor in the management of inoperable metastatic insulinoma: a case report.

    Sawyer AM, Schade DS.

    Endocr Pract. 2008 Oct;14(7):880-3.PMID: 18996817 [PubMed - indexed for MEDLINE]Related articles

    4.

    Metabolic effects of 2 days of strict bed rest.

    Duran-Valdez E, de Serna DG, Schneider S, Amorim F, Burge M, Schade DS.

    Endocr Pract. 2008 Jul-Aug;14(5):564-9.PMID: 18753098 [PubMed - indexed for MEDLINE]Related articles

    5.

    Lispro insulin: benefits and limitations.

    Burge MR, Rassam AG, Schade DS.

    Trends Endocrinol Metab. 1998 Oct 1;9(8):337-41.PMID: 18406299 [PubMed - in process]Related articles

    6.

    Vitamin E in humans: an explanation of clinical trial failure.

    Robinson I, de Serna DG, Gutierrez A, Schade DS.

    Endocr Pract. 2006 Sep-Oct;12(5):576-82. Review.PMID: 17002935 [PubMed - indexed for MEDLINE]Related articles

    7.

    Are insulin pumps underutilized in type 1 diabetes? No.

    Schade DS, Valentine V.

    Diabetes Care. 2006 Jun;29(6):1453-5. No abstract available. PMID: 16732044 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents.

    Maahs D, de Serna DG, Kolotkin RL, Ralston S, Sandate J, Qualls C, Schade DS.

    Endocr Pract. 2006 Jan-Feb;12(1):18-28.PMID: 16524859 [PubMed - indexed for MEDLINE]Related articles

    9.

    To pump or not to pump.

    Schade DS, Wolpert H.

    Diabetes Technol Ther. 2005 Oct;7(5):845-8. Review. No abstract available. PMID: 16241896 [PubMed - indexed for MEDLINE]Related articles

    10.

    The dawn phenomenon revisited: implications for diabetes therapy.

    Carroll MF, Schade DS.

    Endocr Pract. 2005 Jan-Feb;11(1):55-64. Review.PMID: 16033737 [PubMed - indexed for MEDLINE]Related articles

    11.

    Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes.

    Carroll MF, Gutierrez A, Castro M, Tsewang D, Schade DS.

    J Clin Endocrinol Metab. 2003 Nov;88(11):5248-54.PMID: 14602757 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Impact of subclinical hypothyroidism on serum total homocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in the New Mexico Elder Health Survey.

    Lindeman RD, Romero LJ, Schade DS, Wayne S, Baumgartner RN, Garry PJ.

    Thyroid. 2003 Jun;13(6):595-600.PMID: 12930604 [PubMed - indexed for MEDLINE]Related articles

    13.

    Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers.

    Carroll MF, Schade DS.

    Circulation. 2003 Jul 8;108(1):24-31. Epub 2003 Jun 23.PMID: 12821556 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Severe hypoglycemia in adults.

    Carroll MF, Burge MR, Schade DS.

    Rev Endocr Metab Disord. 2003 May;4(2):149-57. Review. No abstract available. PMID: 12766543 [PubMed - indexed for MEDLINE]Related articles

    15.

    A practical approach to hypercalcemia.

    Carroll MF, Schade DS.

    Am Fam Physician. 2003 May 1;67(9):1959-66. Review.PMID: 12751658 [PubMed - indexed for MEDLINE]Related articles

    16.

    Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.

    Carroll MF, Izard A, Riboni K, Burge MR, Schade DS.

    Diabetes Care. 2002 Dec;25(12):2147-52.PMID: 12453952 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Frequency of the dawn phenomenon in type 2 diabetes: implications for diabetes therapy.

    Carroll MF, Hardy KJ, Burge MR, Schade DS.

    Diabetes Technol Ther. 2002;4(5):595-605.PMID: 12450440 [PubMed - indexed for MEDLINE]Related articles

    18.

    To pump or not to pump.

    Schade DS, Valentine V.

    Diabetes Care. 2002 Nov;25(11):2100-2. No abstract available. PMID: 12401763 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effect of smoking on hemoglobin A1c and body mass index in patients with type 2 diabetes mellitus.

    McCulloch P, Lee S, Higgins R, McCall K, Schade DS.

    J Investig Med. 2002 Jul;50(4):284-7.PMID: 12109592 [PubMed - indexed for MEDLINE]Related articles

    20.

    Fasting hyperglycemia predicts the magnitude of postprandial hyperglycemia: implications for diabetes therapy.

    Carroll MF, Izard A, Riboni K, Burge MR, Schade DS.

    Diabetes Care. 2002 Jul;25(7):1247-8. No abstract available. PMID: 12087032 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    The mechanism of glucose-induced catecholamine stimulation.

    Rassam AG, Martin P 3rd, Burge MR, Schade DS.

    Metabolism. 2002 Jun;51(6):761-4.PMID: 12037731 [PubMed - indexed for MEDLINE]Related articles

    22.

    Ten pivotal questions about diabetic ketoacidosis. Answers that clarify new concepts in treatment.

    Carroll MF, Schade DS.

    Postgrad Med. 2001 Nov;110(5):89-92, 95.PMID: 11727655 [PubMed - indexed for MEDLINE]Related articles

    23.

    Effect of short-term glucose control on glycemic thresholds for epinephrine and hypoglycemic symptoms.

    Burge MR, Sobhy TA, Qualls CR, Schade DS.

    J Clin Endocrinol Metab. 2001 Nov;86(11):5471-8.PMID: 11701724 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    A biethnic community survey of cognition in participants with type 2 diabetes, impaired glucose tolerance, and normal glucose tolerance: the New Mexico Elder Health Survey.

    Lindeman RD, Romero LJ, LaRue A, Yau CL, Schade DS, Koehler KM, Baumgartner RN, Garry PJ; New Mexico Elder Health Survey.

    Diabetes Care. 2001 Sep;24(9):1567-72.PMID: 11522700 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Repaglinide dose response? A clinician's viewpoint.

    Schade DS.

    Diabetes Technol Ther. 1999 Fall;1(3):257-8. No abstract available. PMID: 11475270 [PubMed - indexed for MEDLINE]Related articles

    26.

    Potato-lactulose breath hydrogen testing as a function of gastric motility in diabetes mellitus.

    Burge MR, Tuttle MS, Violett JL, Stephenson CL, Schade DS.

    Diabetes Technol Ther. 2000 Summer;2(2):241-8.PMID: 11469266 [PubMed - indexed for MEDLINE]Related articles

    27.

    Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis.

    Burge MR, Garcia N, Qualls CR, Schade DS.

    Metabolism. 2001 Feb;50(2):171-7.PMID: 11229425 [PubMed - indexed for MEDLINE]Related articles

    28.

    Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: a review.

    Burge MR, Sood V, Sobhy TA, Rassam AG, Schade DS.

    Diabetes Obes Metab. 1999 Jul;1(4):199-206. Review. No abstract available. PMID: 11228754 [PubMed - indexed for MEDLINE]Related articles

    29.

    What are the barriers to medical care for patients with newly diagnosed diabetes mellitus?

    Burge MR, Lucero S, Rassam AG, Schade DS.

    Diabetes Obes Metab. 2000 Dec;2(6):351-4.PMID: 11225964 [PubMed - indexed for MEDLINE]Related articles

    30.

    Breath hydrogen testing identifies patients with diabetic gastroparesis.

    Burge MR, Tuttle MS, Violett JL, Stephenson CL, Schade DS.

    Diabetes Care. 2000 Jun;23(6):860-1. No abstract available. PMID: 10841012 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Low-dose epinephrine supports plasma glucose in fasted elderly patients with type 2 diabetes.

    Burge MR, Kamin JR, Timm CT, Qualls CR, Schade DS.

    Metabolism. 2000 Feb;49(2):195-202.PMID: 10690944 [PubMed - indexed for MEDLINE]Related articles

    32.

    Low-dose ethanol predisposes elderly fasted patients with type 2 diabetes to sulfonylurea-induced low blood glucose.

    Burge MR, Zeise TM, Sobhy TA, Rassam AG, Schade DS.

    Diabetes Care. 1999 Dec;22(12):2037-43.PMID: 10587839 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Subclinical hypothyroidism in a biethnic, urban community.

    Lindeman RD, Schade DS, LaRue A, Romero LJ, Liang HC, Baumgartner RN, Koehler KM, Garry PJ.

    J Am Geriatr Soc. 1999 Jun;47(6):703-9.PMID: 10366170 [PubMed - indexed for MEDLINE]Related articles

    34.

    Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.

    Rassam AG, Zeise TM, Burge MR, Schade DS.

    Diabetes Care. 1999 Jan;22(1):133-6.PMID: 10333914 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Effect of immediate-release glipizide on hypoglycemic vulnerability in fasted, elderly patients with type 2 diabetes.

    Burge MR, Schmitz-Fiorentino K, Sood V, Schade DS.

    JAMA. 1999 Mar 24-31;281(12):1084-5. No abstract available. PMID: 10188656 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Outcome of recruitment and report on participation rate in the New Mexico Elder Health Survey.

    Romero LJ, Lindeman RD, Hundley R, Koehler KM, Baumgartner RN, Allen AS, Schade DS, LaRue A, Ortiz IE, Garry PJ.

    Ethn Dis. 1998 Autumn;8(3):350-9.PMID: 9926905 [PubMed - indexed for MEDLINE]Related articles

    37.

    A placebo-controlled, randomized study of glimepiride in patients with type 2 diabetes mellitus for whom diet therapy is unsuccessful.

    Schade DS, Jovanovic L, Schneider J.

    J Clin Pharmacol. 1998 Jul;38(7):636-41.PMID: 9702849 [PubMed - indexed for MEDLINE]Related articles

    38.

    Use of the HemoCue blood glucose analyzer in research studies.

    Rassam AG, Mcleod J, Burge MR, Schade DS.

    Diabetes Care. 1998 Aug;21(8):1369-70. No abstract available. PMID: 9702453 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    General Clinical Research Center Scholars Program.

    Schade DS.

    Acad Med. 1998 May;73(5):616. No abstract available. PMID: 9643941 [PubMed - indexed for MEDLINE]Related articles

    40.

    Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population.

    Lindeman RD, Romero LJ, Hundley R, Allen AS, Liang HC, Baumgartner RN, Koehler KM, Schade DS, Garry PJ.

    Diabetes Care. 1998 Jun;21(6):959-66.PMID: 9614614 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.

    Burge MR, Schmitz-Fiorentino K, Fischette C, Qualls CR, Schade DS.

    JAMA. 1998 Jan 14;279(2):137-43.PMID: 9440664 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Insulins.

    Burge MR, Schade DS.

    Endocrinol Metab Clin North Am. 1997 Sep;26(3):575-98. Review.PMID: 9314016 [PubMed - indexed for MEDLINE]Related articles

    43.

    Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.

    Burge MR, Waters DL, Holcombe JH, Schade DS.

    J Clin Endocrinol Metab. 1997 Mar;82(3):920-4.PMID: 9062507 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Meal composition is a determinant of lispro-induced hypoglycemia in IDDM.

    Burge MR, Castillo KR, Schade DS.

    Diabetes Care. 1997 Feb;20(2):152-5.PMID: 9118763 [PubMed - indexed for MEDLINE]Related articles

    45.

    Diabetes mellitus: 2. Managing type II disease.

    Burge MR, Schade DS.

    Hosp Pract (Minneap). 1996 Dec 15;31(12):51-2, 55-60, 63-6.PMID: 8969679 [PubMed - indexed for MEDLINE]Related articles

    46.

    Diabetes mellitus: 1. Improving control in type I disease.

    Burge MR, Schade DS.

    Hosp Pract (Minneap). 1996 Nov 15;31(11):81-90 passim; discussion 102, 105.PMID: 8941162 [PubMed - indexed for MEDLINE]Related articles

    47.

    Differential effects of physiological versus pathophysiological plasma concentrations of epinephrine and norepinephrine on ketone body metabolism and hepatic portal blood flow in man.

    Krentz AJ, Freedman D, Greene R, McKinley M, Boyle PJ, Schade DS.

    Metabolism. 1996 Oct;45(10):1214-20.PMID: 8843175 [PubMed - indexed for MEDLINE]Related articles

    48.

    Validity of Coat-A-Count insulin RIA kit for quantifying total and free humalog.

    Burge MR, McLeod J, Bowsher RR, Schade DS.

    Clin Chem. 1996 May;42(5):777. No abstract available. PMID: 8653910 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Myocardial atrophy in acquired immunodeficiency syndrome--associated wasting.

    Samaan SA, Foster A, Raizada V, Schade DS, Koster F, Crawford MH.

    Am Heart J. 1995 Oct;130(4):823-7.PMID: 7572592 [PubMed - indexed for MEDLINE]Related articles

    50.

    Brittle diabetes: etiology and treatment.

    Schade DS, Burge MR.

    Adv Endocrinol Metab. 1995;6:289-319. Review.PMID: 7671100 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...